VitaDAO: The Collective Funding Longevity Research
VitaDAO is a decentralized collective funding early stage longevity research. Their mission is to extend human lifespan by researching, financing, and commercializing longevity therapeutics in an open and democratic manner.
We were joined by Tyler Golato and Paul Kohlhaas, co-founders of Molecule and initiators of VitaDAO to talk about how drug discovery and approval currently works, what the status of longevity research is, what role IP plays -- and how all of this could change in the future with DAOs like VitaDAO.
Topics:
- Paul and Tyler's backgrounds and how they came to work on VitaDAO
- Longevity - thinking of aging as a disease
- Where is the research at today?
- How longevity research currently takes place in the pharmaceutical industry
- How VitaDAO is alleviating patency issues
- The first funded project with the Knudsen lab in Copenhagen - Molecule
- How DAOs make the decisions
Links:
Hosts:Friederike Ernst, Meher Roy